Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 2131 AL 2145

A brief history of Aβ imaging

Cohen AD, Villemagne VL.

Alzheimers Dement. 2025 May;21(5):e70291. doi: 10.1002/alz.70291.

Biomarkers of synaptic degeneration in Alzheimer's disease

Cheng Q, Fan Y, Zhang P, Liu H, Han J, Yu Q, Wang X, Wu S, Lu Z.

Ageing Res Rev. 2025 Feb;104:102642. doi: 10.1016/j.arr.2024.102642. Epub 2024 Dec 17.

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

Gonzalez-Ortiz F, Kirsebom BE, Yakoub Y, Gundersen JK, Pålhaugen L, Waterloo K, Selnes P, Jarholm JA, Gísladóttir B, Rongve A, Skogseth RE, Bråthen G, Aarsland D, Turton M, Harrison P, Zetterberg H, Villeneuve S, Fladby T, Blennow K.

Neurology. 2025 Jun 10;104(11):e213676. doi: 10.1212/WNL.0000000000213676. Epub 2025 May 15.

Roles of TREM2 in Alzheimer's disease

Qi X, Zhu K, Ke W, Wang J, Mao S, Chen G.

Transl Neurodegener. 2025 Oct 31;14(1):55. doi: 10.1186/s40035-025-00515-3.

Non-coding RNA biomarkers in Alzheimer's disease

Mohammadpour M, Saeidi K, Ferdosi F, Khanifar H, Dadgostar E, Zakizadeh F, Abdolghaderi S, Khatami SH.

Clin Chim Acta. 2025 Aug 15;576:120427. doi: 10.1016/j.cca.2025.120427. Epub 2025 Jun 14.

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Montoliu-Gaya L, Bian S, Dammer EB, Alcolea D, Sauer M, Martá-Ariza M, Ashton NJ, Belbin O, Fuchs J, Watson CM, Ping L, Duong DM, Nilsson J, Barroeta I, Lantero-Rodriguez J, Videla L, Benejam B, Roberts BR, Blennow K, Seyfried NT, Levey AI, Carmona-Iragui M, Gobom J, Lleó A, Wisniewski T, Zetterberg H, Fortea J, Johnson ECB.

Nat Commun. 2025 Jul 1;16(1):6003. doi: 10.1038/s41467-025-61054-z.

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

Zúñiga CH, Acosta BI, Menchaca R, Amescua CA, Hong S, Hui L, Gil M, Rhee YH, Yoon S, Kim M, Chang PY, Kim YM, Song PY, Betito K.

Alzheimers Res Ther. 2025 Feb 12;17(1):40. doi: 10.1186/s13195-025-01681-2.

The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

McDade EM, Barthélemy NR, Wang G, Li Y, Cao Y, Gordon B, Benzinger TLS, Clifford D, Goate AM, Renton AE, Hassenstab J, Llibre-Guerra JJ, Perrin RJ, Xiong C, Cruchaga C, Mummery CJ, Berman SB, Lah J, Roberson ED, Van Dyck C, Gauthier S, Masters CL, Masellis M, Bittner T, Yaari R, Chhatwal J, Chrem P, Brooks W, Suzuki K, Levin JJ, Jucker M, Ringman J, Wallon D, Ikeuchi T, Lee JH, Roh JH, Schofield P, Fox NC, Ryan NS, Vöglein J, Karch C, Ibáñez L, Day GS, Sánchez-Valle R, Daniels A, Morris JC, Supnet-Bell C, Levey AI, Bateman RJ; DIAN‐TU Study Team and DIAN Obs Team.

Alzheimers Dement. 2025 Sep;21(9):e70689. doi: 10.1002/alz.70689.

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease

Liu X, Baxley S, Hebron M, Turner RS, Moussa C.

Int J Mol Sci. 2025 May 23;26(11):5044. doi: 10.3390/ijms26115044.

An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease

Arnsten AFT, Del Tredici K, Barthélemy NR, Gabitto M, van Dyck CH, Lein E, Braak H, Datta D.

Alzheimers Dement. 2025 Aug;21(8):e70404. doi: 10.1002/alz.70404.

Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis

Pahlke S, Kahale LA, Mahinrad S, Sousa-Pinto B, Vieira RJ, McAteer MB, Claessen T, Contador J, Hofmann A, Kuchenbecker LA, Machado LS, Warmenhoven N, Yakoub Y, Palmqvist S, Schindler SE, Teunissen C, Whitson HE, Zetterberg H, Edelmayer R, Tampi MP.

Alzheimers Dement. 2025 Nov;21(11):e70828. doi: 10.1002/alz.70828.

Proteomic landscape of Alzheimer's disease: emerging technologies, advances and insights (2021 - 2025)

Yarbro JM, Shrestha HK, Wang Z, Zhang X, Zaman M, Chu M, Wang X, Yu G, Peng J.

Mol Neurodegener. 2025 Jul 14;20(1):83. doi: 10.1186/s13024-025-00874-5.

Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity

Mielke MM, Evans JK, Neiberg RH, Molina-Henry DP, Marcovina SM, Johnson KC, Carmichael OT, Rapp SR, Sachs BC, Ding J, Shappell HM, Luchsinger JA, Espeland MA, Hayden KM.

JAMA Netw Open. 2025 Feb 3;8(2):e2458149. doi: 10.1001/jamanetworkopen.2024.58149.

Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology

Rafii MS, Schlachetzki Z, Barroeta I, Head E, Fortea J, Ances BM.

Lancet Neurol. 2025 Sep;24(9):753-762. doi: 10.1016/S1474-4422(25)00237-6.

Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis

Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, Razlighi QR, Shirbandi K, Zhou L, Chen K, Xi K, Banerjee S, Foldi N, Pahlajani S, Glodzik L, Li Y, de Leon MJ, Chiang GC.

Alzheimers Dement. 2025 Feb;21(2):e14458. doi: 10.1002/alz.14458. Epub 2024 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias